OPRX - オプティマイザ―Rx (OptimizeRx Corporation)

OPRXのニュース

   OptimizeRx Completes Platform Integration of TelaRep One-Click Prescriber Connectivity Solution  2022/06/07 12:00:00 Wallstreet:Online
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform - As part of OptimizeRx’s Therapy, Initiation and Persistence Platform, TelaRep is now being used by over 200,000 in-network healthcare providers (HCPs) ROCHESTER, Mich., June 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq:
   OptimizeRx Completes Platform Integration of TelaRep™ One-Click Prescriber Connectivity Solution  2022/06/07 12:00:00 GlobeNewswire
- Launched in April 2020, TelaRep allows doctors to text pharmaceutical representatives directly from within the electronic health record (EHR) platform
   OptimizeRx authorizes $20M share repurchase program  2022/05/17 13:26:37 Seeking Alpha
OptimizeRx (OPRX) has announced that its Board of Directors has unanimously authorized a share repurchase program, under which OptimizeRx may repurchase up to $20M of its…
   OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2022 Results - Earnings Call Transcript  2022/05/05 02:42:10 Seeking Alpha
OptimizeRx Corporation (NASDAQ:NASDAQ:OPRX) Q1 2022 Earnings Conference Call May 04, 2022, 04:30 PM ET Company Participants William Febbo - Chief Executive Officer Ed Stelmakh - Chief…
   OptimizeRx Non-GAAP EPS of -$0.01 in-line, revenue of $13.73M beats by $0.18M  2022/05/04 20:44:25 Seeking Alpha
OptimizeRx press release (OPRX): Q1 Non-GAAP EPS of -$0.01 in-line.Revenue of $13.73M (+22.3% Y/Y) beats by $0.18M.Outlook: The Company is reaffirming its full year financial outlook…
   OptimizeRx Co. (NASDAQ:OPRX) Insider Sells $726,533.67 in Stock  2021/12/24 10:08:42 ETF Daily News
OptimizeRx Co. (NASDAQ:OPRX) insider Stephen L. Silvestro sold 13,241 shares of the companys stock in a transaction dated Friday, December 17th. The stock was sold at an average price of $54.87, for a total transaction of $726,533.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed [] The post OptimizeRx Co. (NASDAQ:OPRX) Insider Sells $726,533.67 in Stock appeared first on ETF Daily News .
   OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes  2021/12/22 13:00:00 Intrado Digital Media
ROCHESTER, Mich., Dec. 22, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the Company) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today issued an open letter from the CEO to shareholders detailing the completion of internal management changes. The full letter is published below:
   Contrasting Capita (OTCMKTS:CTAGY) and OptimizeRx (NASDAQ:OPRX)  2021/12/18 09:34:45 Dakota Financial News
Capita (OTCMKTS:CTAGY) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Volatility and Risk Capita has a beta of 1.02, meaning that its stock price is 2% []
   OptimizeRx (NASDAQ:OPRX) Shares Gap Down to $55.43  2021/12/15 16:44:41 Transcript Daily
OptimizeRx Co. (NASDAQ:OPRX)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $55.43, but opened at $53.87. OptimizeRx shares last traded at $54.97, with a volume of 7 shares trading hands. A number of research analysts have issued reports on OPRX shares. Royal Bank of Canada upped their […]
   OptimizeRx Co. (NASDAQ:OPRX) Receives Average Rating of “Buy” from Brokerages  2021/12/13 23:32:42 Dakota Financial News
OptimizeRx Co. (NASDAQ:OPRX) has been assigned an average rating of “Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month target price among brokerages that have covered […]
   OptimizeRx Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysis  2021/02/23 17:46:00 Stock Market Daily
OptimizeRx announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021 - Stocks News Feed  2021/01/06 12:31:00 Stocks News Feed
ROCHESTER, Mich., Jan. 06, 2021 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at H.C. Wainwright’s BioConnect Conference being held virtually on January 11-14, 2021. The company’s presentation will be available on-demand via the H.C. Wainwright conference portal here and… Read More »OptimizeRx to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
   OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care - Stocks News Feed  2020/12/07 12:31:00 Stocks News Feed
ROCHESTER, Mich., Dec. 07, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has partnered with Komodo Health, a data-driven healthcare software company with access to the broadest array of real-world data across patients, practitioners, and health systems. The partnership integrates Komodo’s… Read More »OptimizeRx Partners with Komodo Health to Expand Life Sciences Support at Point-of-Care
   OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET - Stocks News Feed  2020/10/26 11:31:00 Stocks News Feed
Share this Stock Information ROCHESTER, Mich., Oct. 26, 2020 (GLOBE NEWSWIRE) — OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Monday, November 9, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September… Read More »OptimizeRx Sets Third Quarter 2020 Conference Call for Monday, November 9, 2020 at 4:30 p.m. ET
   FleetCor Technologies (NYSE:FLT) versus OptimizeRx (NYSE:OPRX) Head to Head Contrast  2020/10/23 05:54:41 Dispatch Tribunal
FleetCor Technologies (NYSE:FLT) and OptimizeRx (NASDAQ:OPRX) are both business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings. Profitability This table compares FleetCor Technologies and OptimizeRx’s net margins, return on equity and return on […]

calendar